Recent trial results suggest that CAR T cells may be superior to standard treatments for B-cell NHL that has not responded or has returned after treatment.
/images/jhop/2022/February/Review_CA
Frontiers CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
Non-Hodgkin Lymphoma Treatment - NCI
CAR T-Cell therapy for the management of mantle cell lymphoma, Molecular Cancer
The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma, Experimental Hematology & Oncology
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
Prospects in the management of patients with follicular lymphoma beyond first-line therapy
Driving the next wave of innovation in CAR T-cell therapies
:max_bytes(150000):strip_icc()/Term-Definitions_NDA-438a26fefa014d06b83b75b02d8403a6.jpg)
